Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today tags : Treatment save search
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
PRCT A | $52.77 3.09% 180K
|
Manufacturing
|
| O: 0.78%
H: 0.0%
C: 0.0%
treatment aquablation research biorobotics for meeting therapy
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
PHGE | $0.3201 8.47% 120K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: 0.0%
bx004 congress treatment fibrosis for infections study
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $140.43 7.25% 88K
|
Health Technology
|
| O: 4.09%
H: 0.0%
C: 0.0%
lung approval cancer cell treatment for
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
SILO | $1.96 -1.51% 5M
|
Finance and Insurance
|
| O: 7.65%
H: 0.0%
C: 0.0%
pharma positive treatment for results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
Published: 2024-04-23 (Crawled : 07:00) - prnewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
| Email alert
Add to watchlist
publication treatment research preclinical for leukemia
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $30.45 1.3% 230K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
ABT | News | $107.565 0.46% 610K
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
fda bladder cancer treatment
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
drug candidate treatment for trial response
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PHGE | $0.3201 8.47% 120K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: 0.0%
bx004 treatment fibrosis for study
Gainers vs Losers
| 88% | 12% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.14 39.56% 7.6M
|
Finance
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.